Concepedia

Author

Raymond M. Shaheen

The University of Texas MD Anderson Cancer Center

Also Known As

R M Shaheen, R. M. Shaheen, Rameeza Shaheen, Raymond M Shaheen, Raymond M. Shaheen, Raymond Shaheen

22

Publications

2.4K

Citations

15

H-Index

20

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterSociety of Surgical Oncology
RM

About

Raymond M. Shaheen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and angiogenesis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

1.4K

2

Pathology

7

7

1.4K

3

Immunology

5

5

976

4

Cell Biology

4

4

803

5

Health Sciences

2

2

392

Raymond M. Shaheen

×

14

Publications

2.2K

Citations

14

H-Index

YearCitations

Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.

Raymond M. Shaheen, Darren W. Davis, Wenbiao Liu,

PubMed

1999

337

Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

Dirk B. Mendel, Alexander Laird, Beverly D. Smolich,

PubMed

2000

234

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

Raymond M. Shaheen, Syed A. Ahmad, W. Liu,

British Journal of Cancer

2001

232

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

Niels Reinmuth, Wenbiao Liu, Young Do Jung,

The FASEB Journal

2001

216

The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.

Syed A. Ahmad, Wenbiao Liu, Young Do Jung,

PubMed

2001

211

Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.

Brian K. Zebrowski, S. Yano, W. Liu,

PubMed

1999

196

Vascular Endothelial Growth Factor in Human Colon Cancer: Biology and Therapeutic Implications

Lee M. Ellis, Yutaka Takahashi, Wenbiao Liu,

The Oncologist

2000

196

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

Christiane J. Bruns, Wenbiao Liu, Darren W. Davis,

Cancer

2000

186

Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.

Raymond M. Shaheen, William W. Tseng, Darren W. Davis,

PubMed

2001

162

Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β

Yoshito Akagi, W. Liu, Keping Xie,

British Journal of Cancer

1999

88

Page 1